Send feedback

DYSF p.Ser1711Phe

c.5132C>T · VCV3677022

Likely pathogenic Expert panel
Classification
Likely pathogenic
ClinVar
Review
Expert panel ★★★☆
ClinVar · 3 submitters
AlphaMissense
likely pathogenic
0.9757 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
2
autosomal recessive limb-girdle muscular dystrophy

ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP

Likely Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):

PM2_Supporting PP4_Strong PM3

Curation rationale (ClinGen, verbatim)

The NM_003494.4: c.5015C>T variant in DYSF, which is also known as NM_001130987.2: c.5132C>T p.(Ser1711Phe), is a missense variant predicted to cause substitution of serine to phenylalanine at amino acid 1672, p.(Ser1672Phe). This variant has been reported in at least two patients with features consistent with LGMD (PMID: 33927379, 32528171; LOVD DYSF_001234), where it was identified in unconfirmed phase with a pathogenic variant in both (NM_003494.4: c.797G>A (p.Gly266Glu), 0.5 pts, MYO-SEQ internal data communication, PMID: 32528171; c.799_800del p.(Phe267LeufsTer5), 0.5 pts, PMID: 33927379, LOVD Individuals #00327046 and #0032760) (PM3). At least one of these individuals displayed progressive limb girdle muscle weakness and absent dysferlin on muscle biopsy (PMID: 32528171, MYO-SEQ internal data communication; PP4_Strong). This variant is absent from gnomAD v.4.1.0, meeting the criteria for PM2_Supporting. The computational predictor REVEL gives a score of 0.592, which is below the LGMD VCEP threshold of ≥0.70 (PP3 not met). In summary, this variant meets the criteria to be classified as Likely pathogenic for autosomal recessive limb-girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 2.0.0; 03/23/2026): PM3, PP4_Strong, PM2_Supporting.

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
AlphaMissense0.9757likely pathogenic ✓ concordant with ClinVar · top 7% in DYSF
REVEL0.592indeterminate
SaProtLLR -14.28damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.7GERP 2, phastCons 1
Regional constrainto/e 0.97unconstrained · MANE · 117 kb · p 0.28 · regional, not allelic
Overall
CADD26.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S1672F vs ClinVar S1711F) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene
DYSF
Protein
p.Ser1711Phe
Coding
c.5132C>T
MANE Select
NM_001130987
Type
single nucleotide variant
Location
chr2:71664396 (GRCh38)
Gene constraint
LOEUF 0.836 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.25 · 11 PDB
Full DYSF gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dysf-p-ser1711phe (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown